Tejnaksh Healthcare Ltd Stock Price Today (NSE: TEJNAKSH)
Fundamental Score
Tejnaksh Healthcare Ltd Share Price — Live NSE/BSE Price, Fundamentals & Analysis
Tejnaksh Healthcare Ltd share price today is ₹12.88, down 2.13% on NSE/BSE as of 7 August 2026. Tejnaksh Healthcare Ltd (TEJNAKSH) is a Small-cap company in the Healthcare Service Provider sector with a market capitalisation of ₹28.89 (Cr). The 52-week high for TEJNAKSH share price is ₹19.89 and the 52-week low is ₹10.65. At a P/E ratio of 23.48x, TEJNAKSH is currently trading below its industry average P/E of 42.23x. The company has a Return on Equity (ROE) of 4.64% and a debt-to-equity ratio of 0.01.
Tejnaksh Healthcare Ltd Share Price Chart — NSE/BSE Historical Performance
Tejnaksh Healthcare Ltd share price chart: -8.95% return over the past month. 52-week high ₹19.89, 52-week low ₹10.65.
Tejnaksh Healthcare Ltd — Last 10 Trading Days
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| ₹13.55 | ₹13.55 | ₹12.05 | ₹13.16 | 13.68K (Cr) | |
| ₹14.20 | ₹14.20 | ₹12.98 | ₹13.29 | 33.98K (Cr) | |
| ₹14.20 | ₹14.20 | ₹13.51 | ₹14.00 | 1.15K (Cr) | |
| ₹13.30 | ₹14.10 | ₹13.30 | ₹13.83 | 10.32K (Cr) | |
| ₹13.60 | ₹14.50 | ₹13.01 | ₹13.53 | 12.18K (Cr) | |
| ₹13.62 | ₹14.16 | ₹13.62 | ₹13.96 | 6.08K (Cr) | |
| ₹14.45 | ₹14.45 | ₹13.75 | ₹14.16 | 876.00 (Cr) | |
| ₹14.65 | ₹14.65 | ₹13.75 | ₹13.89 | 2.92K (Cr) | |
| ₹14.10 | ₹14.50 | ₹14.09 | ₹14.40 | 1.58K (Cr) | |
| ₹14.09 | ₹14.40 | ₹13.90 | ₹14.28 | 3.63K (Cr) |
Tejnaksh Healthcare Ltd — Last 12 Months Price History
| Month | Open | High | Low | Close | Change |
|---|---|---|---|---|---|
| ₹13.30 | ₹14.20 | ₹12.05 | ₹13.16 | -1.05% | |
| ₹15.00 | ₹16.29 | ₹13.01 | ₹13.53 | -9.80% | |
| ₹15.65 | ₹15.98 | ₹13.31 | ₹14.77 | -5.62% | |
| ₹16.50 | ₹18.54 | ₹13.30 | ₹15.34 | -7.03% | |
| ₹12.60 | ₹16.99 | ₹11.40 | ₹16.00 | +26.98% | |
| ₹13.99 | ₹15.70 | ₹10.65 | ₹11.93 | -14.72% | |
| ₹14.89 | ₹16.39 | ₹13.07 | ₹13.66 | -8.26% | |
| ₹15.45 | ₹16.33 | ₹12.55 | ₹14.09 | -8.80% | |
| ₹17.25 | ₹17.25 | ₹14.01 | ₹14.99 | -13.10% | |
| ₹17.50 | ₹18.60 | ₹16.02 | ₹16.85 | -3.71% | |
| ₹18.00 | ₹18.88 | ₹16.20 | ₹17.49 | -2.83% | |
| ₹18.49 | ₹19.85 | ₹18.00 | ₹18.09 | -2.16% |
Returns & Performance
Return on Equity (ROE)
Profit generated per ₹1 of shareholder equity
Return on Capital (ROCE)
Returns generated on total capital deployed
Oper. Profit Margin (5Y Avg)
Average operating profit margin over 5 years
Dividend Yield
Annual dividend as % of current share price
Tejnaksh Healthcare Ltd Valuation Check
Price to Earnings (P/E)
Share price ÷ earnings per share. Lower = cheaper
Industry Avg P/E
Average P/E of all peers in this sector
Market Capitalisation
Total market value of all outstanding shares
Growth Engine
Profit Growth (Quarterly YoY)
Net profit growth vs same quarter last year
Revenue Growth (Quarterly YoY)
Revenue growth vs same quarter last year
Revenue Growth (5-Year CAGR)
Compounded annual revenue growth over 5 years
EPS Growth (5-Year CAGR)
Earnings per share growth over 5 years
Net Profit Growth (5-Year CAGR)
Compounded annual net profit growth over 5 years
Balance Sheet Health
Debt to Equity Ratio
Total debt ÷ equity. Below 0.5 = financially healthy
Interest Coverage Ratio
EBIT ÷ interest expense. Above 2.5 = can pay interest comfortably
Free Cash Flow (5-Year Total)
Cash left after capex over 5 years. Positive = self-funded growth
Labels (e.g., "Excellent", "Good") are peer-based vs industry/sector averages — data-only, not advice
Tejnaksh Healthcare Ltd Fundamental Analysis & Valuation Benchmarking
Educational evaluation of TEJNAKSH across key market metrics for learning purposes.
Positive Indicators
6 factors identified
Strong Operating Margins (31.54%)
Observation: Healthy 5-year operating margins indicate pricing power and cost control.
Analysis: OPM >15% suggests operational efficiency and competitive advantages.
Attractive Valuation (P/E: 23.48 vs Industry: 42.23)
Observation: Trading at discount to industry peers.
Analysis: P/E below industry average may present value opportunity.
Conservative Debt Levels (D/E: 0.01)
Observation: Low leverage provides financial flexibility and reduced risk.
Analysis: Conservative debt structure offers resilience during economic downturns.
Strong Interest Coverage (17.40x)
Observation: Earnings comfortably cover interest obligations.
Analysis: Interest coverage >5x indicates low financial distress risk.
Balanced Promoter Holding (73.83%)
Observation: Optimal balance between promoter control and public float.
Analysis: Promoter holding in 50-75% range provides management alignment.
Zero Share Pledging Risk
Observation: No promoter shares pledged as collateral.
Analysis: Absence of share pledging eliminates potential forced-selling pressure.
Risk Factors
8 factors identified
Below-Average Return on Equity (4.64%)
Observation: Returns on equity are below industry benchmarks.
Analysis: ROE <10% may indicate inefficient capital utilization. Consider monitoring for operational improvements and management effectiveness.
Suboptimal ROCE (6.28%)
Observation: Returns on capital employed are below expectations.
Analysis: ROCE <10% suggests potential inefficiencies in capital allocation.
Profit Decline Concern (-29.41%)
Observation: Significant year-over-year profit contraction observed.
Analysis: Declining profitability requires investigation into underlying causes.
Revenue Contraction (-20.56%)
Observation: Sales decline may indicate market challenges or competitive pressures.
Analysis: Negative revenue growth requires analysis of market conditions.
Limited Growth History (-2.04% CAGR)
Observation: Below-average 5-year sales growth trajectory.
Analysis: Low sales CAGR may indicate mature markets or limited growth opportunities.
Weak Earnings Growth (-9.72% CAGR)
Observation: Below-average 5-year EPS growth performance.
Analysis: Low EPS growth may not keep pace with inflation.
Stagnant Profit Growth (-9.71% CAGR)
Observation: Limited 5-year profit growth trajectory.
Analysis: Low profit growth may indicate scalability challenges or market maturity.
No Dividend Distribution
Observation: Company does not currently pay dividends to shareholders.
Analysis: Zero dividend yield may indicate growth reinvestment focus or cash flow constraints.
Tejnaksh Healthcare Ltd vs Healthcare Service Provider Peers
Peer Comparison - Healthcare Service Provider
Compare Tejnaksh Healthcare Ltd with 10 other companies in the same sector
| Company Info | Fundamental | Valuation | Profitability | Financial Health | Growth | Dividend | ||||
|---|---|---|---|---|---|---|---|---|---|---|
Company Company name | Score Bull Run comprehensive fundamental score based on 20+ metrics | Price Current trading price of the stock | Market Cap Total value of all shares in the market | P/E Price per share divided by earnings per share | ROE Net income divided by shareholder equity | ROCE Earnings before interest and tax divided by capital employed | Debt/Eq Total debt divided by total equity | Profit 5Y Average annual profit growth over 5 years | Sales 5Y Average annual sales growth over 5 years | Dividend Annual dividend per share divided by price per share |
Tejnaksh Healthcare LtdTejnaksh Health...Selected✓ TEJNAKSH • 539428 | 28.2/100 | ₹12.88₹13 | ₹28.89₹28.89 | 23.48Average 23.5 Average | 4.64%Poor 4.64% Poor | 6.28%Poor 6.28% Poor | 0.01Excellent 0.0 Excellent | -9.71%Poor -9.71% Poor | -2.04%Poor -2.04% Poor | 0.00% |
Dr Lal PathLabs LtdDr Lal PathLabs... LALPATHLAB • 539524 | 57.7/100 | ₹1905.20₹1905 | ₹28908.91₹28908.91 | 55.39Average 55.4 Average | 22.30%Excellent 22.30% Excellent | 28.00%Excellent 28.00% Excellent | 0.08Excellent 0.1 Excellent | 12.33%Good 12.33% Good | 11.81%Good 11.81% Good | 0.81% |
Vijaya Diagnostic Centre LtdVijaya Diagnost... VIJAYA • 543350 | 67.8/100 | ₹1344.40₹1344 | ₹14307.85₹14307.85 | 82.71Average 82.7 Average | 19.74%Good 19.74% Good | 21.29%Excellent 21.29% Excellent | 0.44Excellent 0.4 Excellent | 15.47%Excellent 15.47% Excellent | 16.66%Excellent 16.66% Excellent | 0.14% |
Metropolis Healthcare LtdMetropolis Heal... METROPOLIS • 542650 | 57.9/100 | ₹582.45₹582 | ₹11858.49₹11858.49 | 60.38Average 60.4 Average | 13.81%Average 13.81% Average | 17.77%Good 17.77% Good | 0.15Excellent 0.1 Excellent | 1.46%Average 1.46% Average | 10.52%Good 10.52% Good | 0.35% |
Thyrocare Technologies LtdThyrocare Techn... THYROCARE • 539871 | 46.7/100 | ₹579.00₹579 | ₹8420.27₹8420.27 | 52.36Average 52.4 Average | 28.40%Excellent 28.40% Excellent | 35.38%Excellent 35.38% Excellent | 0.09Excellent 0.1 Excellent | 8.37%Good 8.37% Good | 10.88%Good 10.88% Good | 1.76% |
Krsnaa Diagnostics LtdKrsnaa Diagnost... KRSNAA • 543328 | 31.9/100 | ₹527.45₹527 | ₹1777.47₹1777.47 | 17.31Average 17.3 Average | 10.89%Average 10.89% Average | 12.70%Average 12.70% Average | 0.54Good 0.5 Good | -11.13%Poor -11.13% Poor | 11.75%Good 11.75% Good | 0.50% |
Suraksha Diagnostic LtdSuraksha Diagno... SURAKSHA • 544293 | 56.2/100 | ₹252.15₹252 | ₹1359.30₹1359.30 | 42.23Average 42.2 Average | 14.12%Average 14.12% Average | 16.97%Good 16.97% Good | 0.53Good 0.5 Good | 31.68%Excellent 31.68% Excellent | 17.26%Excellent 17.26% Excellent | 0.00% |
One Global Service Provider IncOne Global Serv... ONEGLOBAL • 514330 | 82.2/100 | ₹564.95₹565 | ₹1178.25₹1178.25 | 16.95Average 16.9 Average | 65.27%Excellent 65.27% Excellent | 87.02%Excellent 87.02% Excellent | 0.00Excellent 0.0 Excellent | 97.21%Excellent 97.21% Excellent | 167.02%Excellent 167.02% Excellent | 0.00% |
3B Blackbio Diagnostics Ltd3B Blackbio Dia... 3BBLACKBIO • 532067 | 60.3/100 | ₹1248.10₹1248 | ₹1079.13₹1079.13 | 18.42Average 18.4 Average | 19.77%Good 19.77% Good | 25.48%Excellent 25.48% Excellent | 0.01Excellent 0.0 Excellent | -12.44%Poor -12.44% Poor | -8.95%Poor -8.95% Poor | 0.31% |
Sastasundar Ventures LtdSastasundar Ven... SASTASUNDR • 533259 | 39/100 | ₹301.45₹301 | ₹1035.54₹1035.54 | 539.34Average 539.3 Average | 0.29%Poor 0.29% Poor | -0.05%Poor -0.05% Poor | 0.04Excellent 0.0 Excellent | 16.91%Excellent 16.91% Excellent | 19.09%Excellent 19.09% Excellent | 0.00% |
49.4/100 | ₹239.10₹239 | ₹600.78₹600.78 | 20.55Average 20.6 Average | 19.92%Good 19.92% Good | 23.27%Excellent 23.27% Excellent | 0.31Excellent 0.3 Excellent | — — | — — | 0.00% | |
Top Healthcare Service Provider Stocks
View all →By Bull Run Score
By Return on Equity
By Market Cap
- Dr Lal PathLabs Ltd share price28908.91 Cr
- Vijaya Diagnostic Centre Ltd share price14307.85 Cr
- Metropolis Healthcare Ltd share price11858.49 Cr
- Thyrocare Technologies Ltd share price8420.27 Cr
- Krsnaa Diagnostics Ltd share price1777.47 Cr
Tejnaksh Healthcare Ltd PE Ratio History
Historical price-to-earnings ratio for TEJNAKSH — last 5 years
| Year | EPS (₹) | Price (₹) | P/E Ratio |
|---|---|---|---|
| FY 2024 | ₹0.87 | ₹22.51 | 25.9x |
P/E = year-end price ÷ diluted EPS from annual filings. Source: NSE/BSE via Bull Run.
Tejnaksh Healthcare Ltd Quarterly Performance
Latest quarterly metrics for TEJNAKSH — revenue growth and profit growth vs same quarter last year
Revenue Growth (YoY)
-20.56%
Latest quarter vs same quarter previous year
Net Profit Growth (YoY)
-29.41%
Latest quarter net profit vs same quarter previous year
5-Year Revenue CAGR
-2.04%
Compounded annual revenue growth over 5 years
5-Year Profit CAGR
-9.71%
Compounded annual net profit growth over 5 years
Tejnaksh Healthcare Ltd Technical Indicators
SMA 50, SMA 200, RSI and volume signals for TEJNAKSH — calculated from daily price history
Momentum is balanced — neither overbought nor oversold.
Technical indicators are for educational purposes only. Not investment advice.
Tejnaksh Healthcare Ltd Financial Statements
Annual income statement, balance sheet and cash flow for Tejnaksh Healthcare Ltd (TEJNAKSH) — sourced from NSE/BSE filings.
Loading Financial Statements...
Fetching financial data for Tejnaksh Healthcare Ltd
About TEJNAKSH (Tejnaksh Healthcare Ltd)
Tejnaksh Healthcare Ltd is a dynamic healthcare organization committed to delivering comprehensive and innovative medical solutions across India. With a focus on patient-centric ca...re, Tejnaksh operates a diverse network of healthcare facilities, including cutting-edge specialty clinics, advanced diagnostic centers, and state-of-the-art hospitals. Dedicated to providing accessible and affordable healthcare, Tejnaksh leverages its extensive infrastructure and experienced medical professionals to cater to a wide range of medical needs. The organization distinguishes itself through a commitment to continuous improvement and embracing technological advancements to enhance patient outcomes and overall well-being. Driven by a passion for excellence, Tejnaksh Healthcare Ltd offers a wide spectrum of specialized services, from highly specialized treatments in urology and advanced dental care to comprehensive medical care across various disciplines. The company operates advanced pathology and stone analysis labs, ensures accurate and timely diagnostics. Furthermore, Tejnaksh is dedicated to fostering the next generation of healthcare professionals through its educational institutes, super-specialty training programs, and simulation labs, contributing significantly to the advancement of medical knowledge and expertise within the country. Beyond providing direct medical services, Tejnaksh Healthcare Ltd actively engages in the distribution of essential healthcare equipment, medical supplies, and pharmaceutical products, ensuring a holistic approach to patient care. This integrated approach allows Tejnaksh to effectively address the multifaceted healthcare needs of the communities it serves, strengthening its position as a trusted and reliable healthcare partner. Tejnaksh strives to contribute to a healthier India through quality services, education, and ethical practices.
Company Details
Key Leadership
Latest News
TEJNAKSH Share Price: Frequently Asked Questions
What is the current share price of Tejnaksh Healthcare Ltd?
Tejnaksh Healthcare Ltd (TEJNAKSH) trades at ₹12.88 on NSE and BSE. Market cap ₹28.89 (Cr). Educational data only.
What is the P/E ratio of Tejnaksh Healthcare Ltd?
Tejnaksh Healthcare Ltd has a P/E of 23.48x vs industry average 42.23x.
What is the Bull Run score for Tejnaksh Healthcare Ltd?
Tejnaksh Healthcare Ltd has a Bull Run score of 28.2/100 based on 25+ financial parameters.
Does Tejnaksh Healthcare Ltd pay dividends?
Tejnaksh Healthcare Ltd has a dividend yield of 0.00%. Past dividends don't guarantee future payments.
What is the ROE of Tejnaksh Healthcare Ltd?
Tejnaksh Healthcare Ltd has ROE of 4.64%. Higher ROE indicates better use of shareholder equity.
What is the debt-to-equity ratio of Tejnaksh Healthcare Ltd?
Tejnaksh Healthcare Ltd has debt-to-equity of 0.01.
Is Tejnaksh Healthcare Ltd a good investment?
Bull Run gives Tejnaksh Healthcare Ltd a score of 28.2/100. This is not investment advice — consult a SEBI-registered advisor.